As per DelveInsight’s assessment, the Breast Cancer Diagnostics Market is expected to grow at an immense pace in the coming years owing to the rising prevalence of breast cancer, increasing age and sedentary lifestyle, government initiatives to increase the rate of screening, technological advancements.
DelveInsight’s “Breast Cancer Diagnostics Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Breast Cancer Diagnostics companies actively working in the market.
Breast Cancer Diagnostics
Breast Cancer is a type of cancer that generally starts in the breasts, it can occur only in one breast or both. Men are much less likely than women to develop breast cancer. Breast lumps, bloody nipple discharge, and changes in the nipple’s or breast’s shape or texture are all indications of breast cancer. The cancer’s stage determines the course of treatment.
Breast cancer tests are utilized to find the disease in both men and women displaying its symptoms. By offering care at the earliest point feasible, early diagnosis could enhance cancer treatment.
Breast Cancer Diagnostics Market Insights
Geographically, The global market for breast cancer diagnostics is anticipated to be dominated by North America in 2021 and continue to do so from 2022 to 2027. The demand for breast cancer diagnostics in the North American market is driven by factors like aging, race, and ethnicity. All these factors would provide a conducive growth environment for the North American region in the breast cancer diagnostics market.
To know more about why North America is leading the market growth in the Breast Cancer Diagnostics market, get a snapshot of the report Breast Cancer Diagnostics Market Trends
Recent Developments in the Breast Cancer Diagnostics Market Report
- In Jan 2021, Kheiron’s AI Breast Screening Solution Mia Receives Regulatory Clearance in Australia and New Zealand
- In Nov 2021, Kheiron Medical Technologies Launched RSViP to Help U.S. Breast Screening Programs Tackle Backlogs Worsened by COVID-19
- In Jan 2022, UE LifeSciences entered into a definitive distribution agreement with Siemens Healthineers, adding its flagship device iBreastExam to Siemens’ 360-degree breast care product portfolio for the U.S. market
- In March 2022, Niramai gets US FDA clearance for their first medical device, SMILE-100 System (breast thermography device)
To read more about the latest highlights related to Breast Cancer Diagnostics, get a snapshot of the key highlights entailed in the Breast Cancer Diagnostics
Key Players in the Breast Cancer Diagnostics Market
Some of the key market players operating in the Breast Cancer Diagnostics market include Niramai Health Analytix, UE LifeSciences Inc, Xuzhou AKX Electronic Science And Technology Co Ltd, Kheiron Medical Technologies Limited, Technomax Corporation, General Electric Company, Hologic Inc, Koninklijke Philips N.V, Fujifilm Corporation, Canon Medical Systems Argentina S.A, Hitachi Ltd, Carestream Health, Planmed Oy, SonoCiné, Seno Medical, Stryker, Izotropic Corporation, Koning Health, Siemens Healthcare GmbH, CMR Naviscan, and others.
COVID-19 Impact Analysis on the Breast Cancer Diagnostics Market
The main drivers of the breast cancer diagnostics market are the increasing prevalence of breast cancer, increasing age and sedentary lifestyle, technological advancements, government initiatives to increase the rate of screening and diagnosis. As a result, the need for breast cancer diagnostics increased due to the rising incidence of breast cancer worldwide, driving the market for breast cancer diagnostics market to rise throughout the forecast period (2022-2027).
Additionally, as hospital admissions for patients with cancer and other illnesses were not prioritized in comparison to those with the COVID-19 pandemic, this had a minor negative influence on the market for Breast cancer diagnostics. In addition to lockdown regulations, a lack of employees, a lack of masks, and a lack of PPE kits had a significant impact on the number of breast cancer patients admitted to hospitals. The breast cancer diagnostics market, however, has gained traction as a result of widespread vaccination and is anticipated to continue expanding throughout the course of the projection period.
Scope of the Breast Cancer Diagnostics Market Report
- Coverage: Global
- Study Period: 2019–2027
- Market Segmentation By Product Type: Instrument, Reagent, and Consumables, and others
- Market Segmentation By End User: Hospitals, Diagnostic Laboratories, Cancer Research Centers, And Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Breast Cancer Diagnostics Companies: Niramai Health Analytix, UE LifeSciences Inc, Xuzhou AKX Electronic Science And Technology Co Ltd, Kheiron Medical Technologies Limited, Technomax Corporation, General Electric Company, Hologic Inc, Koninklijke Philips N.V, Fujifilm Corporation, Canon Medical Systems Argentina S.A, Hitachi Ltd, Carestream Health, Planmed Oy, SonoCiné, Seno Medical, Stryker, Izotropic Corporation, Koning Health, Siemens Healthcare GmbH, CMR Naviscan, among others
DelveInsight Analysis: The Breast Cancer Diagnostics market in the 7MM was valued at USD 4.20 Billion in the year 2021 and is anticipated to grow with a CAGR of 6.66% during the forecasted period (2022–-2027)
Which MedTech key players in the Breast Cancer Diagnostics market are set to emerge as the trendsetter explore @ Breast Cancer Diagnostics
Table of Contents
| 1 | Breast Cancer Diagnostics Market Report Introduction |
| 2 | Breast Cancer Diagnostics Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Breast Cancer Diagnostics Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Breast Cancer Diagnostics Market |
| 7 | Breast Cancer Diagnostics Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11. | About DelveInsight |
Interested in knowing how the Breast Cancer Diagnostics market will grow by 2027? Click to get a snapshot of the Breast Cancer Diagnostics Market Analysis
Related Reports
Endoscopy Cameras Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopy Cameras Market companies including Olympus Corporation, Stryker, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, SCHÖLLY FIBEROPTIC GMBH, among others.
Endoscopes Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopes Market companies, including Boston Scientific Corporation, CONMED Corporation, OLYMPUS CORPORATION, PENTAX Medical, among others.
Disposable Endoscopes Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Disposable Endoscopes Market companies, including Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Hill-Rom Services, Inc. (Baxter), among others.
Endoscopic Ultrasound Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopic Ultrasound Market companies, including Abbott, Olympus, Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, among others.
Gastrointestinal Endoscopic Stricture Management Devices Market
Gastrointestinal Endoscopic Stricture Management Devices Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and Gastrointestinal Endoscopic Stricture Management Devices Market companies including Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Abbott, Olympus, Intuitive Surgical Inc, among others.
Other Trending Reports
Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market
Latest Healthcare Blogs
Genital Warts Treatment Market
Top Cardiac Devices For Heart Disease Prevention
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Gaurav Bora
+1(919)321-6187